SlideShare ist ein Scribd-Unternehmen logo
1 von 50
Downloaden Sie, um offline zu lesen
TRANSDERMAL DRUG DELIVERY
PRESENTED BY..
SUSHMITA
M PHARM
Transdermal drug delivery can deliver drugs via
the skin portal to systemic circulation at a
predetermined rate and maintain clinically
effective concentrarion over a prolonged period
of time.
Percutaneous Absorption
The absorption of substances from
outside the skin to positions beneath the skin,
including entrance into the blood stream
Penetration of the Skin by Drugs
Drugs may penetrate intact skin after
topical application (a)through the walls of the
hair follicles,(b) through the sweat glands or the
sebaceous glands, (c) or between the cells of the
horny layer.
Are designed to support the passage of drug
substances from the surface of the skin, through
its various layers, and into the systemic
circulation.
The main route for the penetration of drug is
generally through the epidermal layers, rather
than through the hair follicles or the gland ducts,
because the surface area of the latter is rather
minute compared to the area of the skin.
The percutaneous absorption of a drug
generally results from direct penetration
of the drug through the stratum
corneum.
Permeation of the laminate barriers in stratum
corneum can occur by diffusion via:
1. Transcellular penetration (across the
cells)
2. Intercellular penetration (between the cells)
3. Transappendageal penetration (via hair
follicles, sweat and sebum glands, and
pilosebaceous apparatus)
Sebaceous glandCorneocytes
Intracellular lipid
Transappendageal route
Intercellular route
Sweat duct
Hair follicle
Intracellular lipid
matrix
Epidermis
Dermis
Subcutaneous
ayer
STRUCTURE OF SKIN
Epidermis:
 The outer layer of skin is made up of Stratified
Squamous epithelial cells.
Epidermis is thickest in palms and soles.
The stratum corneum forms the outer most layer (10-
15µm thick ) which consists of many layers of compacted
, flattened, dehydrated keratinized cells.
Keratin contains cells called as Corneosites.
 Stratum corneum layer forms permeability barrier for
external environment. 8
DERMIS:
 The dermis is made up of regular network of robust
collagen fibers of fairly uniform thickness with regularly
placed cross striations .
This network or the gel structure is responsible for the
elastic properties of the skin.
It is supplied by blood to convey nutrients, remove waste &
regulate body temp.
Drug is well absorbed by this route.
Upper portion of the dermis is formed into ridges
containing lymphatics and nerve endings.
9
STRUCTURE OF SKIN
SUBCUTANEOUS TISSUE:
This is a sheet of the fat containing areolar tissue
known as the superficial fascia attaching the dermis to the
underlying structures .
SKIN APPENDAGES:
Sweat glands produces sweat of pH 4-6.8 & absorbs
drugs, secretes proteins, lipids and antibodies. Its function
is to control heat.
HAIR FOLLICLES
They have sebaceous glands which produces sebum
and includes glycerides, cholesterol and squalene. 10
STRUCTURE OF SKIN
MECHANISM OF ABSORPTION THROUGH SKIN
Mechanism involved is passive diffusion
This can be expressed by FICK’s LAW of DIFFUSION
dq = D K A ( c1 – c2 )
dt h
dq /dt = rate of diffusion
D = diffusion co-efficient
K = partition co- efficient
A = surface area of membrane
H = thickness of membrane
11
ROUTES OF DRUG ABSORPTION THROUGH SKIN
 Trans follicular route
 Trans epidermal route
12
ROUTES OF DRUG ABSORPTION THROUGH SKIN
 Trans follicular route:
 Fractional area available through this route is 0.1 %
 Human skin contains 40-70 hair follicles, 200 to 250
sweat glands on every sq.cm. of skin area.
 Mainly water soluble substance are diffused faster
through appendages than that of other layers.
 Sweat glands and hair follicles act as a shunt i.e. easy
pathway for diffusion through rate limiting ST corneum.
13
ROUTES OF DRUG ABSORPTION THROUGH SKIN
 Trans Epidermal route
 Epidermal barrier function mainly resides in horny layer
 The viable layer may metabolize, inactivate or activate a
prodrug.
 Dermal capillary contains many capillaries so residence
time of drug is only one minute.
 Within stratum corneum molecule may penetrate either
transcellularly or intercellular.
 Intracellular region is filled with lipid rich amorphous
material.
14
ROUTES OF DRUG ABSORPTION THROUGH SKIN
15
Avoidance of first pass metabolism
Avoidance of gastro intestinal incompatibility
Predictable and extended duration of activity
Provides utilization of drugs with short biological half
lives
Narrow therapeutic window
 Improving physiological and pharmacological response
Avoiding the fluctuation in drug levels
Maintain plasma concentration of potent drugs
Greater patient compliance due to elimination of
multiple dosing profile
Ability to deliver drug more selectively to a specific site
Provide suitability for self administration
Enhance therapeutic efficacy
The drug must have some desirable physicochemical
properties for penetration through stratum corneum.
The transdermal delivery will be very difficult, if the
drug dose required is more than 10 mg/day for their
therapeutic application.
Only relatively potent drugs are suitable candidates for
TDDS.
The barrier function of the skin changes from one site to
another on the same person, from person to person and
with age.
•Polymer matrix / Drug reservoir.
•Drug.
•Permeation enhancers.
•Pressure sensitive adhesive (PSA).
•Backing laminates.
•Release liner.
•Natural Polymers :Cellulose Derivatives, Zein,
Gelatin, Shellac,Waxes, Gums and Chitosan.
•SyntheticsElastomers:Polyisobutylene,Silicon
Rubber, Nitrile,Acrylonitrile, Neoprene,Butylrubber.
•SyntheticPolymers:Polyvinyl
Alcohol,Polyvinylchloride,
Polyethylene, Polypropylene,Polyacrylate, Polyamide,
Polyurea,Polyvinylpyrrolidone.
Chemical Enhancers
•Increasing the drug permeability through the skin by
causing reversible damage to the SC.
•Conditioning the SC to promote drug diffusion.
•Increasing the partition coefficient of the drug to
promote its release from the vehicle into the skin.
Materials used to enhance absorption: surfactants,
azone,dimethylsulfoxide(DMSO),dimethylacetamide,
alcohol, acetone, propylene glycol, and polyethylene
glycol.
Physical Enhancers: Iontophoresis
Sonophoresis
Iontophoresis involves the delivery of charged
chemical compounds across the skin membrane using
an applied electrical field.
Examples: lidocaine, amino acids/peptides/insulin, verapamil,
and propanolol
Sonophoresis, or high-frequency ultrasound, is also
being studied as a means to enhance transdermal drug
delivery
Examples: hydrocortisone, lidocaine, and salicylic acid in such
formulations as gels, creams and lotions
A PSA maintains an intimate contact between
patch and the skin surface. It should adhere with
not more than applied finger pressure, be
aggressively and permanently tachy, and exert a
strong holding force. For example polyacrylates,
polyisobutylene and silicon based adhesives.
The primary function of the backing laminate is to
provide support.Backing layer should be chemical
resistant and excipient compatible because the
prolonged contact between the backing layer and the
excipient may cause the additives to leach out or may
lead to diffusion of excipient,drug or penetration
enhancer through the layer.
EXAMPLES of some backing material are Aluminium
vapor coated layer,polyethylene,PVC films etc.
During storage the patch is covered by a protective liner
that is removed and discharged immediately before the
application of the patch to skin. It is therefore regarded as
a part of the primary packaging material rather than a part
of dosage form for delivering the drug.
Typically, release liner is
composed of a base layer which may be non-
occlusive(e.g. paper fabric) or occlusive
(e.g.polyethylene, polyvinylchloride) and a release
coating layer made up of silicon or teflon.
Backing
Drug in adhesive
Membrane
Drug in adhesive
Linear
Sushmita[transdermal]
FACTORS AFFECTING
TRANSDERMAL PERMEABILITY
 Physico chemical properties of parent molecule
 Solubility and partition co- efficient
 pH condition
 Penetrant concentration
 Physico chemical properties of drug delivery system
 Release characteristic
 Composition of drug delivery system
 Permeation enhancer used
28
 Physiological and pathological condition of skin
Lipid film
Skin hydration
Skin temperature
Effect of vehicle
Pathological injury to skin
 Biological factors
Skin age
Thickness of S. Corneum
Skin condition
29
Solubility and partition co- efficient:
 Solubility of a drug influences its ability to penetrate
the skin.
 pKa is index of solubility of drug in vehicle and ST
corneum has influence on transfer of drug from vehicle
to skin.
Drug solubility determines concentration presented to
absorption site which will effect rate and extent of
absorption.
 Skin permeation can be enhanced by increasing
lipophilic character of drug, so that drug penetrates
through STC but not through epidermis due to decreased
water solubility.
 Drug which is lipid & water soluble is favored.
30
pH & penetration concentration:
 Moderate pH is favorable because if solutions with high
or low pH will result in destruction to the skin.
 Higher the concentration of the drug in vehicle faster
the absorption.
 At higher concentrations than solubility the excess solid
drug will function as a reservoir and helps to maintain a
constant drug constitution for prolonged period of time.
31
1.Physicochemical evaluation.
2. In vitro evaluation.
3. In vivo evaluation.
•Appearance.
•Thickness.
•Uniformity of weight.
•Drug content determination.
•Rolling ball tack test.
•Thumb Tack test.
•Skin Irritation study.
•Moisture content.
•%Moisture Uptake.
•Tensile Strength.
Thickness of the patch
The thickness of the
drug prepared patch is measured by using a
digital micrometer at different point of patch
and determines the average thickness and
standard deviation for the same to ensure the
thickness of the prepared patch
34
Content uniformity test
10 patches are selected and
content is determined for individual patches. If 9 out of
10 patches have content between 85% to 115% of the
specified value and one has content not less than 75% to
125% of the specified value , then transdermal patches
pass the test of content uniformity. But if 3 patches have
content in the range of 75% to 125%,then additional 20
patches are tested for drug content. If these 20 patches
have range from 85% to 115%, then the transdermal
patches pass the test
35
Drug content determination
An accurately weighed
portion of film (above 100 mg) is dissolved in 100 mL
of suitable solvent in which drug is soluble and then the
solution is shaken continuously for 24 h in shaker
incubator. Then the wholesolution is sonicated. After
sonication and subsequent filtration, drug in solution is
estimated spectrophotometrically by
appropriate dilution
36
 Moisture content:
The prepared films are weighed individually and
kept in a desiccators containing calcium chloride at
room temperature for 24 h. The films are weighed
again after a specified interval until they show a
constant weight. The percent moisture content is
calculated using following formula.
Initial wt. – Final Wt.
% Moisture content = ---------------------------------
X100
Final weight
37
 Moisture Uptake:
Weighed film sare kept in a desiccator at room temperature
for 24 h. These are then taken out and exposed to 84%
relative humidity
using saturated solution of Potassium chloride in a desiccator
until a constant
weight is achieved. % moisture uptake is calculated as given
below.
Final weight – Initial weight
% moisture uptake =---------------------------------- X 100
Initial weight
38
To determine tensile
strength , polymeric
films are sandwiched
separately by corked
linear iron plates
One end of the films is kept
fixed with the help of an
iron screen and other end is
connected to a freely
movable thread over a
pulley
1 2 3 4 5 6 7 8 9 10 11 12
Weight
PulleyFilm
Thread
The weights are added
gradually to the pan
attached with the hanging
end of the thread
A pointer on the thread
is used to measure the
elongation of the film.
The weight just
sufficient to break the
film is noted
Tensile strength= F/a.b (1+L/l)
F= is the force required to break
a=width of film
b=thickness of film;
L= length of film
l=elongation of film at break point.
•The Paddle over Disc(USP apparatus 5)
•The Cylinder modified USP Basket(USP apparatus 6)
•The reciprocating disc(USP apparatus 7)
.Animal models.
•Human volunteers.
•The highest selling transdermal patch in the United
States is the nicotine patch, which releases nicotine in
controlled doses to help with cessation of tobacco
smoking.
•Nitroglycerin patches are sometimes prescribed for the
treatment of angina in lieu of sublingual pills.
•The anti-hypertensive drug Clonidine is available in
transdermal patch form.
•Transdermal form of the MAOI selegiline, became the
first transdermal delivery agent for an antidepressant.
1. Clonidine - Catapress -TTS
Four-layered patch:(1) backing layer of
pigmented polyester film (2) drug reservoir of
clonidine, mineral oil, polyisobutylene, and colloidal
silicon dioxide, (3) a microporous polypropylene
membrane controlling the rate of drug delivery, and (4)
an adhesive formulation of agents
Uses: antihypertensive clonidine at a constant rate
for 7 days, once a week dosing in the upper arm
or torso.
2. Estradiol - Estraderm
Four layered patch: (1) transparent polyester film,
(2) drug reservoir of estradiol and alcohol gelled
with hydroxypropyl cellulose, (3) an ethylenevinyl
acetate copolymer membrane, and (4) an
adhesive formulation of light mineral and
polyisobutylene.
Uses: design to release 17 B-estradiol continuously.
Applied twice weekly over a cycle of 3 weeks.
The patch is generally applied to the abdomen,
altering sites with each application.
3. Nicotine - Nicotrol
Multi-layered rectangular patch: (1)outer backing of
laminated polyester film, (2) rate-controlling adhesive,
nonwoven material, and nicotine, (3) disposable liner
removed prior to use - Aid in smoking cessation
programs.
It is used as a temporary aid for smoking-cessation programs. It
helps to control the symptoms of nicotine withdrawal
(irritability, headache, fatigue, insomnia) and thus helps you to
concentrate on overcoming the psychological and behavioral
aspects of your smoking habit.
4.Nitroglycerin - Nitro - Dur
Nitroglycerin in a gel like matrix composed of
glycerin, water, lactose, polyvinyl alcohol, povidone
and sodium citrate sealed in a polyester foil
polyethylene laminate.
Use: to provide controlled release of nitroglycerin
continuously for a 24 hour period. Patches are
applied to inner part of upper arm, shoulders, or
chest.
This is a band-aid-like patch inserted on your gum to
numb it before an injection
Thank
you

Weitere ähnliche Inhalte

Was ist angesagt?

Nasal Drug Delivery System
 Nasal Drug Delivery System Nasal Drug Delivery System
Nasal Drug Delivery SystemNaman Pant
 
Approaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccinesApproaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccinesshikha singh
 
Osmotic activated drug delivery system
Osmotic activated drug delivery systemOsmotic activated drug delivery system
Osmotic activated drug delivery systemMehak AggarwAl
 
Protein and peptide drug delivery system
Protein and peptide drug delivery systemProtein and peptide drug delivery system
Protein and peptide drug delivery systemRajat Singh
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery systemPravin Chinchole
 
Sustained and controlled drug delivery system
Sustained and controlled drug delivery systemSustained and controlled drug delivery system
Sustained and controlled drug delivery systemprashant bhamare
 
Transport models biopharamaceutics
Transport models biopharamaceuticsTransport models biopharamaceutics
Transport models biopharamaceuticsSUJITHA MARY
 
Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)PRABU12345678
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.Mohammad Imran
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemBinuja S.S
 
Controlled release drug delivery system2
Controlled release drug delivery system2Controlled release drug delivery system2
Controlled release drug delivery system2Bansari Patel
 
Gastroretentive drug delivery system by mali vv
Gastroretentive drug delivery system by mali vvGastroretentive drug delivery system by mali vv
Gastroretentive drug delivery system by mali vvVidhyaMali1
 
oral controlled drug delivery system
oral controlled drug delivery systemoral controlled drug delivery system
oral controlled drug delivery systemBaliram Musale
 
Barriers to Protein and peptide drug delivery system
Barriers to Protein and peptide drug delivery system   Barriers to Protein and peptide drug delivery system
Barriers to Protein and peptide drug delivery system JaskiranKaur72
 
Mechanically activated drug delivery system
Mechanically activated drug delivery systemMechanically activated drug delivery system
Mechanically activated drug delivery systemMehak AggarwAl
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery systemdoll969
 
SUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power pointSUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power pointSonam Gandhi
 

Was ist angesagt? (20)

Nasal Drug Delivery System
 Nasal Drug Delivery System Nasal Drug Delivery System
Nasal Drug Delivery System
 
Approaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccinesApproaches for delivery of protein, peptides & vaccines
Approaches for delivery of protein, peptides & vaccines
 
Osmotic activated drug delivery system
Osmotic activated drug delivery systemOsmotic activated drug delivery system
Osmotic activated drug delivery system
 
Protein and peptide drug delivery system
Protein and peptide drug delivery systemProtein and peptide drug delivery system
Protein and peptide drug delivery system
 
Buccal drug delivery system
Buccal drug delivery systemBuccal drug delivery system
Buccal drug delivery system
 
Sustained and controlled drug delivery system
Sustained and controlled drug delivery systemSustained and controlled drug delivery system
Sustained and controlled drug delivery system
 
Transport models biopharamaceutics
Transport models biopharamaceuticsTransport models biopharamaceutics
Transport models biopharamaceutics
 
Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)
 
Pulmonary drug delivery system.
Pulmonary drug delivery system.Pulmonary drug delivery system.
Pulmonary drug delivery system.
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Controlled release drug delivery system2
Controlled release drug delivery system2Controlled release drug delivery system2
Controlled release drug delivery system2
 
Colon specific drug delivery system
Colon specific drug delivery systemColon specific drug delivery system
Colon specific drug delivery system
 
Gastroretentive drug delivery system by mali vv
Gastroretentive drug delivery system by mali vvGastroretentive drug delivery system by mali vv
Gastroretentive drug delivery system by mali vv
 
oral controlled drug delivery system
oral controlled drug delivery systemoral controlled drug delivery system
oral controlled drug delivery system
 
Barriers to Protein and peptide drug delivery system
Barriers to Protein and peptide drug delivery system   Barriers to Protein and peptide drug delivery system
Barriers to Protein and peptide drug delivery system
 
Parenteral controlled release drug delivery systems
Parenteral controlled release drug delivery systemsParenteral controlled release drug delivery systems
Parenteral controlled release drug delivery systems
 
Mechanically activated drug delivery system
Mechanically activated drug delivery systemMechanically activated drug delivery system
Mechanically activated drug delivery system
 
Drug targeting to particular organs
Drug targeting to particular organsDrug targeting to particular organs
Drug targeting to particular organs
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery system
 
SUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power pointSUSTAINDRUG DELIVERY SYSTEMS power point
SUSTAINDRUG DELIVERY SYSTEMS power point
 

Andere mochten auch

Folleto curso virtual
Folleto curso virtualFolleto curso virtual
Folleto curso virtualLina MolaNo
 
Capsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash VilegaveCapsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash VilegaveKailash Vilegave
 
Sustained release property
Sustained release propertySustained release property
Sustained release propertySonam Gandhi
 
Skin relating problems in cosmetics
Skin relating problems in cosmeticsSkin relating problems in cosmetics
Skin relating problems in cosmeticssushmita rana
 
Materiales innovadores para la realización de capsulas
Materiales innovadores para la realización de capsulasMateriales innovadores para la realización de capsulas
Materiales innovadores para la realización de capsulasBessy Caroiz
 
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMDr Gajanan Sanap
 
Quality risk management
Quality risk managementQuality risk management
Quality risk managementimran bakshi
 
Goods and services
Goods and servicesGoods and services
Goods and servicesImran Alam
 
Implant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery SystemImplant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery Systembiniyapatel
 
parenteral drug delivery systemsSnehal pdds ppt
parenteral drug delivery systemsSnehal pdds  pptparenteral drug delivery systemsSnehal pdds  ppt
parenteral drug delivery systemsSnehal pdds pptsnehal dhobale
 
Lipatick ppt (2)))))
Lipatick ppt  (2)))))Lipatick ppt  (2)))))
Lipatick ppt (2)))))Anay Kacharia
 
Common skin diseases
Common skin diseasesCommon skin diseases
Common skin diseasesDjagna
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemDanish Kurien
 
Transdermal drug delivery system ppt
Transdermal drug delivery system pptTransdermal drug delivery system ppt
Transdermal drug delivery system pptDeepak Sarangi
 

Andere mochten auch (20)

Folleto curso virtual
Folleto curso virtualFolleto curso virtual
Folleto curso virtual
 
Capsule
CapsuleCapsule
Capsule
 
Metodo lengua-francesa
Metodo lengua-francesaMetodo lengua-francesa
Metodo lengua-francesa
 
Capsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash VilegaveCapsule 1 manufacturing and qc test by Kailash Vilegave
Capsule 1 manufacturing and qc test by Kailash Vilegave
 
Implants
ImplantsImplants
Implants
 
Plant layout
Plant layoutPlant layout
Plant layout
 
Sustained release property
Sustained release propertySustained release property
Sustained release property
 
Skin relating problems in cosmetics
Skin relating problems in cosmeticsSkin relating problems in cosmetics
Skin relating problems in cosmetics
 
Materiales innovadores para la realización de capsulas
Materiales innovadores para la realización de capsulasMateriales innovadores para la realización de capsulas
Materiales innovadores para la realización de capsulas
 
Cápsulas
CápsulasCápsulas
Cápsulas
 
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEM
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Goods and services
Goods and servicesGoods and services
Goods and services
 
Implant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery SystemImplant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery System
 
parenteral drug delivery systemsSnehal pdds ppt
parenteral drug delivery systemsSnehal pdds  pptparenteral drug delivery systemsSnehal pdds  ppt
parenteral drug delivery systemsSnehal pdds ppt
 
Lipatick ppt (2)))))
Lipatick ppt  (2)))))Lipatick ppt  (2)))))
Lipatick ppt (2)))))
 
Implants
ImplantsImplants
Implants
 
Common skin diseases
Common skin diseasesCommon skin diseases
Common skin diseases
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Transdermal drug delivery system ppt
Transdermal drug delivery system pptTransdermal drug delivery system ppt
Transdermal drug delivery system ppt
 

Ähnlich wie Sushmita[transdermal]

transdermal drug delivery system
transdermal drug delivery systemtransdermal drug delivery system
transdermal drug delivery systemSaloniBhandari7
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systemsSonam Gandhi
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemRavish Yadav
 
Unit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfUnit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfbijaybhattarai942
 
Transdermal Drug Delivery System
Transdermal Drug Delivery System Transdermal Drug Delivery System
Transdermal Drug Delivery System silambarasan I
 
transdermaldrugdeliverysystem-181012051415 (1).pptx
transdermaldrugdeliverysystem-181012051415 (1).pptxtransdermaldrugdeliverysystem-181012051415 (1).pptx
transdermaldrugdeliverysystem-181012051415 (1).pptxasadsana1006
 
transdermaldrugdeliverysystem-181012051415 (1).pdf
transdermaldrugdeliverysystem-181012051415 (1).pdftransdermaldrugdeliverysystem-181012051415 (1).pdf
transdermaldrugdeliverysystem-181012051415 (1).pdfNikhilThakur992764
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemArshad Khan
 
TRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.Durgamani
TRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.DurgamaniTRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.Durgamani
TRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.DurgamaniGvDurgamani
 
C-11 TRANSDERMAL.ppt
C-11 TRANSDERMAL.pptC-11 TRANSDERMAL.ppt
C-11 TRANSDERMAL.pptShikha Swetha
 
Transdermaldrugdeliverysystem 190410095922
Transdermaldrugdeliverysystem 190410095922Transdermaldrugdeliverysystem 190410095922
Transdermaldrugdeliverysystem 190410095922venkatagaveshbabu
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery systemD.R. Chandravanshi
 
transdermal drug delievery system novel approach to deliever the drug
transdermal drug delievery system novel approach to deliever the drugtransdermal drug delievery system novel approach to deliever the drug
transdermal drug delievery system novel approach to deliever the drugTarun Kalia
 
Transdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash VilegaveTransdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash VilegaveKailash Vilegave
 
TRANS_DERMAL_DRUG_DELIVERY._SYSTEM Bpptx
TRANS_DERMAL_DRUG_DELIVERY._SYSTEM BpptxTRANS_DERMAL_DRUG_DELIVERY._SYSTEM Bpptx
TRANS_DERMAL_DRUG_DELIVERY._SYSTEM Bpptxexamcellmrpharmacy
 
transdermal drug delivery system
transdermal drug delivery systemtransdermal drug delivery system
transdermal drug delivery systemBiva Biscuity
 

Ähnlich wie Sushmita[transdermal] (20)

transdermal drug delivery system
transdermal drug delivery systemtransdermal drug delivery system
transdermal drug delivery system
 
Tdds1
Tdds1Tdds1
Tdds1
 
Transdermal drug delivery systems
Transdermal drug delivery systemsTransdermal drug delivery systems
Transdermal drug delivery systems
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Unit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfUnit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdf
 
Transdermal Drug Delivery System
Transdermal Drug Delivery System Transdermal Drug Delivery System
Transdermal Drug Delivery System
 
transdermaldrugdeliverysystem-181012051415 (1).pptx
transdermaldrugdeliverysystem-181012051415 (1).pptxtransdermaldrugdeliverysystem-181012051415 (1).pptx
transdermaldrugdeliverysystem-181012051415 (1).pptx
 
transdermaldrugdeliverysystem-181012051415 (1).pdf
transdermaldrugdeliverysystem-181012051415 (1).pdftransdermaldrugdeliverysystem-181012051415 (1).pdf
transdermaldrugdeliverysystem-181012051415 (1).pdf
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Tdds
TddsTdds
Tdds
 
TRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.Durgamani
TRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.DurgamaniTRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.Durgamani
TRANSDERMAL DRUG DELIVERY SYSTEM BY PRATUSH PATNAIK uploaded by G.V.Durgamani
 
C-11 TRANSDERMAL.ppt
C-11 TRANSDERMAL.pptC-11 TRANSDERMAL.ppt
C-11 TRANSDERMAL.ppt
 
TDDS.docx
TDDS.docxTDDS.docx
TDDS.docx
 
Transdermaldrugdeliverysystem 190410095922
Transdermaldrugdeliverysystem 190410095922Transdermaldrugdeliverysystem 190410095922
Transdermaldrugdeliverysystem 190410095922
 
Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
transdermal drug delievery system novel approach to deliever the drug
transdermal drug delievery system novel approach to deliever the drugtransdermal drug delievery system novel approach to deliever the drug
transdermal drug delievery system novel approach to deliever the drug
 
Transdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash VilegaveTransdermal drug delivery system by Kailash Vilegave
Transdermal drug delivery system by Kailash Vilegave
 
TRANS_DERMAL_DRUG_DELIVERY._SYSTEM Bpptx
TRANS_DERMAL_DRUG_DELIVERY._SYSTEM BpptxTRANS_DERMAL_DRUG_DELIVERY._SYSTEM Bpptx
TRANS_DERMAL_DRUG_DELIVERY._SYSTEM Bpptx
 
Transdermal Drug Delivery System
Transdermal Drug Delivery SystemTransdermal Drug Delivery System
Transdermal Drug Delivery System
 
transdermal drug delivery system
transdermal drug delivery systemtransdermal drug delivery system
transdermal drug delivery system
 

Kürzlich hochgeladen

pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 

Kürzlich hochgeladen (20)

pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 

Sushmita[transdermal]

  • 1. TRANSDERMAL DRUG DELIVERY PRESENTED BY.. SUSHMITA M PHARM
  • 2. Transdermal drug delivery can deliver drugs via the skin portal to systemic circulation at a predetermined rate and maintain clinically effective concentrarion over a prolonged period of time.
  • 3. Percutaneous Absorption The absorption of substances from outside the skin to positions beneath the skin, including entrance into the blood stream Penetration of the Skin by Drugs Drugs may penetrate intact skin after topical application (a)through the walls of the hair follicles,(b) through the sweat glands or the sebaceous glands, (c) or between the cells of the horny layer.
  • 4. Are designed to support the passage of drug substances from the surface of the skin, through its various layers, and into the systemic circulation.
  • 5. The main route for the penetration of drug is generally through the epidermal layers, rather than through the hair follicles or the gland ducts, because the surface area of the latter is rather minute compared to the area of the skin.
  • 6. The percutaneous absorption of a drug generally results from direct penetration of the drug through the stratum corneum. Permeation of the laminate barriers in stratum corneum can occur by diffusion via: 1. Transcellular penetration (across the cells) 2. Intercellular penetration (between the cells) 3. Transappendageal penetration (via hair follicles, sweat and sebum glands, and pilosebaceous apparatus)
  • 7. Sebaceous glandCorneocytes Intracellular lipid Transappendageal route Intercellular route Sweat duct Hair follicle Intracellular lipid matrix Epidermis Dermis Subcutaneous ayer
  • 8. STRUCTURE OF SKIN Epidermis:  The outer layer of skin is made up of Stratified Squamous epithelial cells. Epidermis is thickest in palms and soles. The stratum corneum forms the outer most layer (10- 15µm thick ) which consists of many layers of compacted , flattened, dehydrated keratinized cells. Keratin contains cells called as Corneosites.  Stratum corneum layer forms permeability barrier for external environment. 8
  • 9. DERMIS:  The dermis is made up of regular network of robust collagen fibers of fairly uniform thickness with regularly placed cross striations . This network or the gel structure is responsible for the elastic properties of the skin. It is supplied by blood to convey nutrients, remove waste & regulate body temp. Drug is well absorbed by this route. Upper portion of the dermis is formed into ridges containing lymphatics and nerve endings. 9 STRUCTURE OF SKIN
  • 10. SUBCUTANEOUS TISSUE: This is a sheet of the fat containing areolar tissue known as the superficial fascia attaching the dermis to the underlying structures . SKIN APPENDAGES: Sweat glands produces sweat of pH 4-6.8 & absorbs drugs, secretes proteins, lipids and antibodies. Its function is to control heat. HAIR FOLLICLES They have sebaceous glands which produces sebum and includes glycerides, cholesterol and squalene. 10 STRUCTURE OF SKIN
  • 11. MECHANISM OF ABSORPTION THROUGH SKIN Mechanism involved is passive diffusion This can be expressed by FICK’s LAW of DIFFUSION dq = D K A ( c1 – c2 ) dt h dq /dt = rate of diffusion D = diffusion co-efficient K = partition co- efficient A = surface area of membrane H = thickness of membrane 11
  • 12. ROUTES OF DRUG ABSORPTION THROUGH SKIN  Trans follicular route  Trans epidermal route 12
  • 13. ROUTES OF DRUG ABSORPTION THROUGH SKIN  Trans follicular route:  Fractional area available through this route is 0.1 %  Human skin contains 40-70 hair follicles, 200 to 250 sweat glands on every sq.cm. of skin area.  Mainly water soluble substance are diffused faster through appendages than that of other layers.  Sweat glands and hair follicles act as a shunt i.e. easy pathway for diffusion through rate limiting ST corneum. 13
  • 14. ROUTES OF DRUG ABSORPTION THROUGH SKIN  Trans Epidermal route  Epidermal barrier function mainly resides in horny layer  The viable layer may metabolize, inactivate or activate a prodrug.  Dermal capillary contains many capillaries so residence time of drug is only one minute.  Within stratum corneum molecule may penetrate either transcellularly or intercellular.  Intracellular region is filled with lipid rich amorphous material. 14
  • 15. ROUTES OF DRUG ABSORPTION THROUGH SKIN 15
  • 16. Avoidance of first pass metabolism Avoidance of gastro intestinal incompatibility Predictable and extended duration of activity Provides utilization of drugs with short biological half lives Narrow therapeutic window  Improving physiological and pharmacological response
  • 17. Avoiding the fluctuation in drug levels Maintain plasma concentration of potent drugs Greater patient compliance due to elimination of multiple dosing profile Ability to deliver drug more selectively to a specific site Provide suitability for self administration Enhance therapeutic efficacy
  • 18. The drug must have some desirable physicochemical properties for penetration through stratum corneum. The transdermal delivery will be very difficult, if the drug dose required is more than 10 mg/day for their therapeutic application. Only relatively potent drugs are suitable candidates for TDDS. The barrier function of the skin changes from one site to another on the same person, from person to person and with age.
  • 19. •Polymer matrix / Drug reservoir. •Drug. •Permeation enhancers. •Pressure sensitive adhesive (PSA). •Backing laminates. •Release liner.
  • 20. •Natural Polymers :Cellulose Derivatives, Zein, Gelatin, Shellac,Waxes, Gums and Chitosan. •SyntheticsElastomers:Polyisobutylene,Silicon Rubber, Nitrile,Acrylonitrile, Neoprene,Butylrubber. •SyntheticPolymers:Polyvinyl Alcohol,Polyvinylchloride, Polyethylene, Polypropylene,Polyacrylate, Polyamide, Polyurea,Polyvinylpyrrolidone.
  • 21. Chemical Enhancers •Increasing the drug permeability through the skin by causing reversible damage to the SC. •Conditioning the SC to promote drug diffusion. •Increasing the partition coefficient of the drug to promote its release from the vehicle into the skin. Materials used to enhance absorption: surfactants, azone,dimethylsulfoxide(DMSO),dimethylacetamide, alcohol, acetone, propylene glycol, and polyethylene glycol.
  • 22. Physical Enhancers: Iontophoresis Sonophoresis Iontophoresis involves the delivery of charged chemical compounds across the skin membrane using an applied electrical field. Examples: lidocaine, amino acids/peptides/insulin, verapamil, and propanolol Sonophoresis, or high-frequency ultrasound, is also being studied as a means to enhance transdermal drug delivery Examples: hydrocortisone, lidocaine, and salicylic acid in such formulations as gels, creams and lotions
  • 23. A PSA maintains an intimate contact between patch and the skin surface. It should adhere with not more than applied finger pressure, be aggressively and permanently tachy, and exert a strong holding force. For example polyacrylates, polyisobutylene and silicon based adhesives.
  • 24. The primary function of the backing laminate is to provide support.Backing layer should be chemical resistant and excipient compatible because the prolonged contact between the backing layer and the excipient may cause the additives to leach out or may lead to diffusion of excipient,drug or penetration enhancer through the layer. EXAMPLES of some backing material are Aluminium vapor coated layer,polyethylene,PVC films etc.
  • 25. During storage the patch is covered by a protective liner that is removed and discharged immediately before the application of the patch to skin. It is therefore regarded as a part of the primary packaging material rather than a part of dosage form for delivering the drug. Typically, release liner is composed of a base layer which may be non- occlusive(e.g. paper fabric) or occlusive (e.g.polyethylene, polyvinylchloride) and a release coating layer made up of silicon or teflon.
  • 28. FACTORS AFFECTING TRANSDERMAL PERMEABILITY  Physico chemical properties of parent molecule  Solubility and partition co- efficient  pH condition  Penetrant concentration  Physico chemical properties of drug delivery system  Release characteristic  Composition of drug delivery system  Permeation enhancer used 28
  • 29.  Physiological and pathological condition of skin Lipid film Skin hydration Skin temperature Effect of vehicle Pathological injury to skin  Biological factors Skin age Thickness of S. Corneum Skin condition 29
  • 30. Solubility and partition co- efficient:  Solubility of a drug influences its ability to penetrate the skin.  pKa is index of solubility of drug in vehicle and ST corneum has influence on transfer of drug from vehicle to skin. Drug solubility determines concentration presented to absorption site which will effect rate and extent of absorption.  Skin permeation can be enhanced by increasing lipophilic character of drug, so that drug penetrates through STC but not through epidermis due to decreased water solubility.  Drug which is lipid & water soluble is favored. 30
  • 31. pH & penetration concentration:  Moderate pH is favorable because if solutions with high or low pH will result in destruction to the skin.  Higher the concentration of the drug in vehicle faster the absorption.  At higher concentrations than solubility the excess solid drug will function as a reservoir and helps to maintain a constant drug constitution for prolonged period of time. 31
  • 32. 1.Physicochemical evaluation. 2. In vitro evaluation. 3. In vivo evaluation.
  • 33. •Appearance. •Thickness. •Uniformity of weight. •Drug content determination. •Rolling ball tack test. •Thumb Tack test. •Skin Irritation study. •Moisture content. •%Moisture Uptake. •Tensile Strength.
  • 34. Thickness of the patch The thickness of the drug prepared patch is measured by using a digital micrometer at different point of patch and determines the average thickness and standard deviation for the same to ensure the thickness of the prepared patch 34
  • 35. Content uniformity test 10 patches are selected and content is determined for individual patches. If 9 out of 10 patches have content between 85% to 115% of the specified value and one has content not less than 75% to 125% of the specified value , then transdermal patches pass the test of content uniformity. But if 3 patches have content in the range of 75% to 125%,then additional 20 patches are tested for drug content. If these 20 patches have range from 85% to 115%, then the transdermal patches pass the test 35
  • 36. Drug content determination An accurately weighed portion of film (above 100 mg) is dissolved in 100 mL of suitable solvent in which drug is soluble and then the solution is shaken continuously for 24 h in shaker incubator. Then the wholesolution is sonicated. After sonication and subsequent filtration, drug in solution is estimated spectrophotometrically by appropriate dilution 36
  • 37.  Moisture content: The prepared films are weighed individually and kept in a desiccators containing calcium chloride at room temperature for 24 h. The films are weighed again after a specified interval until they show a constant weight. The percent moisture content is calculated using following formula. Initial wt. – Final Wt. % Moisture content = --------------------------------- X100 Final weight 37
  • 38.  Moisture Uptake: Weighed film sare kept in a desiccator at room temperature for 24 h. These are then taken out and exposed to 84% relative humidity using saturated solution of Potassium chloride in a desiccator until a constant weight is achieved. % moisture uptake is calculated as given below. Final weight – Initial weight % moisture uptake =---------------------------------- X 100 Initial weight 38
  • 39. To determine tensile strength , polymeric films are sandwiched separately by corked linear iron plates One end of the films is kept fixed with the help of an iron screen and other end is connected to a freely movable thread over a pulley 1 2 3 4 5 6 7 8 9 10 11 12 Weight PulleyFilm Thread
  • 40. The weights are added gradually to the pan attached with the hanging end of the thread A pointer on the thread is used to measure the elongation of the film. The weight just sufficient to break the film is noted Tensile strength= F/a.b (1+L/l) F= is the force required to break a=width of film b=thickness of film; L= length of film l=elongation of film at break point.
  • 41. •The Paddle over Disc(USP apparatus 5) •The Cylinder modified USP Basket(USP apparatus 6) •The reciprocating disc(USP apparatus 7)
  • 43. •The highest selling transdermal patch in the United States is the nicotine patch, which releases nicotine in controlled doses to help with cessation of tobacco smoking. •Nitroglycerin patches are sometimes prescribed for the treatment of angina in lieu of sublingual pills. •The anti-hypertensive drug Clonidine is available in transdermal patch form. •Transdermal form of the MAOI selegiline, became the first transdermal delivery agent for an antidepressant.
  • 44. 1. Clonidine - Catapress -TTS Four-layered patch:(1) backing layer of pigmented polyester film (2) drug reservoir of clonidine, mineral oil, polyisobutylene, and colloidal silicon dioxide, (3) a microporous polypropylene membrane controlling the rate of drug delivery, and (4) an adhesive formulation of agents Uses: antihypertensive clonidine at a constant rate for 7 days, once a week dosing in the upper arm or torso.
  • 45. 2. Estradiol - Estraderm Four layered patch: (1) transparent polyester film, (2) drug reservoir of estradiol and alcohol gelled with hydroxypropyl cellulose, (3) an ethylenevinyl acetate copolymer membrane, and (4) an adhesive formulation of light mineral and polyisobutylene. Uses: design to release 17 B-estradiol continuously. Applied twice weekly over a cycle of 3 weeks. The patch is generally applied to the abdomen, altering sites with each application.
  • 46. 3. Nicotine - Nicotrol Multi-layered rectangular patch: (1)outer backing of laminated polyester film, (2) rate-controlling adhesive, nonwoven material, and nicotine, (3) disposable liner removed prior to use - Aid in smoking cessation programs.
  • 47. It is used as a temporary aid for smoking-cessation programs. It helps to control the symptoms of nicotine withdrawal (irritability, headache, fatigue, insomnia) and thus helps you to concentrate on overcoming the psychological and behavioral aspects of your smoking habit.
  • 48. 4.Nitroglycerin - Nitro - Dur Nitroglycerin in a gel like matrix composed of glycerin, water, lactose, polyvinyl alcohol, povidone and sodium citrate sealed in a polyester foil polyethylene laminate. Use: to provide controlled release of nitroglycerin continuously for a 24 hour period. Patches are applied to inner part of upper arm, shoulders, or chest.
  • 49. This is a band-aid-like patch inserted on your gum to numb it before an injection